Advertisement

Topics

Companies Related to "Positron Emission Tomography in Extrapulmonary Tuberculosis" [Most Relevant Company Matches] - Page: 4 RSS

08:47 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Positron Emission Tomography in Extrapulmonary Tuberculosis" found in our extensive corporate database of over 50,000 company records.

Showing "Positron Emission Tomography Extrapulmonary Tuberculosis" Companies 76–94 of 94

Probably Relevant

VisionGate, Inc.

VisionGate, Inc. is led by Dr. Alan Nelson, physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. VisionGate offers the first automated 3D cell imaging platform, the Cell-CT, which computes high-resolution 3D biosignatures f...


Axion Health Inc.

The ReadySet Program allows organizations in industries such as healthcare, energy, pharmaceuticals, financial services, government to create flexible, dynamic and affordable Workforce Emergency Preparedness and Response programs with integrated clinical services and compliance. The ReadySet Web-based program helps ensure workforce availability and continuity of operations by protecting employees,...

The Millennium Foundation

The Millennium Foundation for Innovative Finance for Health ("Millennium Foundation") is a Swiss not-for-profit organization created in 2008 whose mission is to create a sustainable source of needed additional funding to achieve the three health-related Millennium Development Goals agreed to by the United Nations in 2000: to treat and fight life-threatening diseases, including HIV/AIDS, malaria an...


Genlantis

Genlantis, a division of Gene Therapy Systems, Inc. is located in San Diego, California. Genlantis designs, develops and commercializes biological reagents for life scientists worldwide. The Company is focused on the development of protein expression tools as well as efficient delivery technologies for both in vitro and in vivo applications. Genlantis offers a comprehensive line of specialty produ...

Dynawell International AG

DynaWellTM is a privately owned Sweden based medical technology company founded in 1998.Our mission is to assist medical professionals by offering sophisticated diagnostic techniques for CT and MRI scanners. This provides a more accurate diagnosis to enhance the possibility of optimal and cost-effective treatment. Ultimately, we strive to help people who are experiencing pain or discomfort to retu...

PuriCore plc

PuriCore plc (LSE:PURI) is a water-based clean technology company focused on developing and commercializing proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore’s patented, proprietary technology mimics the human body’s production of the nat...

ImmunoBiology Limited (ImmBio)

Limited [ImmBio] is a biotechnology company specialising in the treatment of infectious diseases and cancer. ImmBio's approach is to apply advances in the emerging science of Immunobiology to the development of treatments for infections diseases and cancer. Immbio is developing a proprietary vaccine technology based on these advances. The platform technology is called HspC™ vaccination. HspC...

Johnson and Johnson (France)

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. These diseases range from cancer, HIV/AIDS and bacterial infections to schizophrenia, epilepsy, rheumatoid arthritis and psoriasis. In 2007, we invested $5.3 billion in the search for new ways to treat these diseases and many others. It’s all part of our commitment to helping you an...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II many dreaded infectious diseases such as diphtheria, pneumonia, syphilis, and tuberculosis disappeared almost overnight. However all is not well with the antibiotics story. The bacterial pathogens are f...

Possibly Relevant

Chembio Diagnostic Systems, Inc.

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Chembio’s focus is on developing, manufacturing and marketing tests for the rapid, simple and cost-effective detection of HIV, Tuberculosis (human and veterinary), and certain other Neglected Diseases...

CBSET

CBSET — Concord Biomedical Sciences & Emerging Technologies — is the preclinical research leader in critically important therapeutic fields such as interventional cardiology, renal disease and dialysis, chronic drug-resistant hypertension, women’s health, minimally invasive surgery, orthopedics, biological and synthetic tissue repair, drug delivery...

InBios International, Inc.

InBios International, Inc. is a medical diagnostic company that specializes in developing, manufacturing and marketing medical diagnostic tests for the detection of infectious diseases. Since its inception in 1996, InBios has developed proprietary technologies useful in the development of rapid and ELISA based immunodiagnostic assays. It has also licensed antigens from major corporations and resea...

AB BIODISK

The AB BIODISK name, company spirit and reputation are based on commitment to the highest standards of science. The company is perhaps best known for its dedication to antimicrobial resistance testing since the early 1950s. The mission left by its scientific founder, Hans Ericsson, Professor of Microbiology at the Karolinska Institute, “to Promote the Rational Use of Antibiotics” has been fait...

ProUroCare Medical

Proprietary vision technologies advancing the safety and efficacy of medical diagnostics and therapeutics. ProUroCare Medical Inc. is an early-stage company that is developing innovative sensing and vision technologies to increase the safety and efficacy of medical diagnostics and therapeutic procedures. Currently, we are focused on products and technologies that use minimally invasive techniqu...

AC Vaccine technology

The AC Vaccine technology is a therapuetic treatment based on the concept of haptenization. This idea has a long history, beginning with the work of the immunologist and Nobel laureate Karl Landsteiner in the 1920’s. He and other scientists showed in animal models that attaching a small chemical (a hapten) to a protein allowed that protein to be recognized by the immune system even if the anim...

Gen-Probe Life Sciences Ltd

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more rapidly and/or accurately than older testing methods, and have therefore become one of the fast...

Long Island Clinical Research Associates

Long Island Clinical Research Associates, LLP (LICRA) is an affiliate organization of Nassau Gastroenterology Associates, P.C. We are a privately owned clinical research center in Great Neck, New York. Conveniently located to New York City and its suburbs, LICRA services a multi-racial and multi-ethnic population of more than 12 million, allowing recruitment from a diverse group of clinical study ...

Syngene

Syngene is a world leader in gel documentation (gel doc) and analysis systems. These range from low cost entry level kits to fully computer controlled automatic analysers for fluorescence, chemiluminescence and proteomics workstations. • Gel documentation (gel doc) and image analysis systems for DNA and protein gels. • Chemiluminescence and fluorescence systems for Western blots and probes. ...

Tri-Institutional Therapeutics Discovery Institute, Inc

The independent, nonprofit institute, which will have its own scientific advisory board and board of directors, will build a strong bridge between early-stage research discoveries and the development of new diagnostic and therapeutic agents for myriad health challenges, reflecting the diverse interests of the member institutions’ faculty. Projects that will be tackled could range from addr...


More From BioPortfolio on "Positron Emission Tomography in Extrapulmonary Tuberculosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks